Heat Biologics reports interim phase II data on HS-110 with nivolumab in advanced NSCLC Feb. 10, 2021
Agenus reports additional confirmed objective clinical responses from phase I/II trial of AGEN-1181 Feb. 10, 2021
AC Immune begins first-in-human study of ACI-12589 as diagnostic for Parkinson's disease Feb. 10, 2021
Basilea reports cohort 1 data from phase II study of derazantinib in intrahepatic cholangiocarcinoma Feb. 10, 2021
NeuroRx reports preliminary phase IIb/III trial data on Zyesami in COVID-19 respiratory failure Feb. 10, 2021
RSS